July 19, 2008
Michael J. Fox Foundation gave $5.6M for a Phase 2 clinical trial to investigate potential of inosine in treating Parkinson's disease.
July 31 - Developing nonprofit leaders: Emotional intelligence in the workplace, details
August 28- A new look at executive and board leadership, Greenville, details